STOCK TITAN

Inmune Bio Inc (INMB) Net Income by Year

INMB

Inmune Bio Inc reported a net loss of $46.0M in fiscal year 2025. This represents a decrease of 9.5% from the prior fiscal year. The table below carries 9 fiscal years, from 2017 to 2025, and the quarters Inmune Bio Inc has filed alongside them.

FY2025 annual
Net Income -$46.0M
YoY -9.5%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

INMB Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-K
Net Income-$46.0M-9.5%-$42.0M-40.0%-$30.0M-9.9%-$27.3M+10.0%-$30.3M-150.8%-$12.1M-57.6%-$7.7M+38.3%-$12.4M-1396.1%-$831K

INMB Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$1.3M+94.8%-$5.4M+44.5%N/A-$6.5M+46.5%-$24.5M-151.0%-$9.7M+11.7%N/A-$12.1M-41.2%-$9.7M-49.9%-$11.0M-68.7%-$8.4M-44.0%-$8.6M-10.8%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Inmune Bio Inc financials

Frequently Asked Questions

What was Inmune Bio Inc's net income in fiscal year 2025?

Inmune Bio Inc reported a net loss of $46.0M in fiscal year 2025.

How fast is Inmune Bio Inc's net income growing?

Inmune Bio Inc (INMB) net income fell by 9.5% year over year, from -$42.0M to -$46.0M in fiscal year 2025.

How has Inmune Bio Inc's net income changed over the years?

Across the 9 fiscal years this page covers, Inmune Bio Inc (INMB) net income went from -$831K in fiscal year 2017 to -$46.0M in fiscal year 2025.

Inmune Bio Inc (INMB) reported -$1.3M in net income in Q2 2026. This represents an increase of 94.8% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Inmune Bio Inc (INMB) reported on that line in every period on record.